Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|January 7, 1998
Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamideC A Peloquin, G S Jaresko, C L Yong, et al.Pharmacotherapy|July 1, 1994
Pharmacokinetic evaluation of aconiazide, a potentially less toxic isoniazid prodrugC A Peloquin, G T James, L D Craig, et al.The Journal of Antimicrobial Chemotherapy|March 17, 2000
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variablesJ Q Tran, C H Ballow, A Forrest, et al.The Journal of Infectious Diseases|December 1, 1993
Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex diseaseS M Gordon, C R Horsburgh, C A Peloquin, et al.Antimicrobial Agents and Chemotherapy|January 20, 2021
Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance SuppressionG L Drusano, Stephanie Rogers, David Brown, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 4, 2021
Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosisL H Cameron, C A Peloquin, P Hiatt, et al.Journal of Veterinary Pharmacology and Therapeutics|February 22, 2005
Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)J N Maslow, S K Mikota, M Zhu, et al.HIV Medicine|October 30, 2009
Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteersA D Luber, D V Condoluci, P D Slowinski, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 1, 2021
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian childrenN A H Seneadza, S Antwi, H Yang, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2002
Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreakP Spradling, D Drociuk, S McLaughlin, et al.Pageof 8